Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis
- PMID: 29042794
- PMCID: PMC5633279
- DOI: 10.2147/OTT.S141968
Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis
Abstract
Background and aims: Hepatic resection (HRN) and microwave ablation (MWA) have significant advantages in treating hepatocellular carcinoma; however, it remains unclear which way produces better outcomes. This meta-analysis of cohort studies compared the treatments in terms of effectiveness and safety.
Methods: Six electronic databases (PubMed, Medline, EMBASE, Web of Science, EBSCO, and The Cochrane Library) were retrieved for studies comparing MWA and HRN. The meta-analysis was conducted based on statement of preferred reporting items for systematic reviews and meta-analyses.
Results: Nine studies met the inclusion criteria, with a total of 1,480 patients. The overall meta-analysis demonstrated no significant difference in overall survival between the MWA group and the HRN group (HR =0.98, 95% CI =0.76-1.26, P=0.878). There was no difference in disease-free survival between the MWA group and the HRN group (HR =1.16, 95% CI =0.79-1.71, P=0.442). Meanwhile, the meta-analysis demonstrated that MWA was associated with shorter operation time (standardized mean difference [SMD] =-1.37, 95% CI =-1.92 to -0.81, P=0.000), less amount of blood loss in operation (SWD =-1.19, 95% CI =-1.76 to -0.61, P=0.000), and less complications (OR =0.22, 95% CI =0.12-0.40, P=0.000) than HRN.
Conclusion: In conclusion, our meta-analysis suggests that MWA may be superior to HRN as it is as effective as HRN in terms of overall survival, disease-free survival, tumor recurrence, and is associated with shorter operation time, less amount of blood loss, and fewer complications.
Keywords: hepatic resection; microwave ablation; primary hepatic carcinoma; survival analysis.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures










Similar articles
-
Microwave ablation compared with hepatic resection for the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis.World J Surg Oncol. 2019 Jun 10;17(1):98. doi: 10.1186/s12957-019-1632-6. World J Surg Oncol. 2019. PMID: 31182102 Free PMC article.
-
Microwave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysis.J Cancer Res Ther. 2020;16(2):379-386. doi: 10.4103/jcrt.JCRT_403_19. J Cancer Res Ther. 2020. PMID: 32474527
-
Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.Int J Hyperthermia. 2019;36(1):264-272. doi: 10.1080/02656736.2018.1562571. Epub 2019 Jan 24. Int J Hyperthermia. 2019. PMID: 30676100
-
Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis.Onco Targets Ther. 2019 Aug 13;12:6407-6438. doi: 10.2147/OTT.S204340. eCollection 2019. Onco Targets Ther. 2019. PMID: 31496742 Free PMC article.
-
Comparison of the safety and efficacy of hepatic resection and radiofrequency ablation in the treatment of single small hepatocellular carcinoma: systematic review and meta-analysis.Transl Cancer Res. 2022 Mar;11(3):580-590. doi: 10.21037/tcr-22-563. Transl Cancer Res. 2022. PMID: 35402177 Free PMC article.
Cited by
-
Short-term efficacy of microwave ablation in the treatment of liver cancer and its effect on immune function.World J Clin Cases. 2024 Jun 26;12(18):3395-3402. doi: 10.12998/wjcc.v12.i18.3395. World J Clin Cases. 2024. PMID: 38983409 Free PMC article.
-
Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.Eur Radiol. 2023 Mar;33(3):1938-1948. doi: 10.1007/s00330-022-09135-1. Epub 2022 Sep 17. Eur Radiol. 2023. PMID: 36114849
-
Percutaneous microwave ablation of hepatic lesions near the heart.Transl Gastroenterol Hepatol. 2021 Oct 25;6:59. doi: 10.21037/tgh-20-314. eCollection 2021. Transl Gastroenterol Hepatol. 2021. PMID: 34805581 Free PMC article.
-
Precision oncology: The role of minimally-invasive ablation therapy in the management of solid organ tumors.World J Radiol. 2025 Jan 28;17(1):98618. doi: 10.4329/wjr.v17.i1.98618. World J Radiol. 2025. PMID: 39876886 Free PMC article. Review.
-
Effects of Interphase and Interpulse Delays on Tissue Impedance and Pulsed Field Ablation.Ann Biomed Eng. 2025 Aug;53(8):1962-1974. doi: 10.1007/s10439-025-03757-4. Epub 2025 May 16. Ann Biomed Eng. 2025. PMID: 40380020 Free PMC article.
References
-
- Jemal A, Bray F, Melissa M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. - PubMed
-
- Torre LA, Bray F, Rebecca L, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. - PubMed
-
- Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134(7):1908–1916. - PubMed
-
- Gravante G, Overton J, Sorge R, et al. Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg. 2011;15(2):378–387. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous